335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
A brief summary of this episode
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.
A brief summary of this episode
The skinny isn't ready yet — notes appear once the transcript is processed.